Chenggang Li, Hanchuan Shen, Yang Liu, Tianci Zhao, Chaoxian Li. "Adjuvant donafenib plus anti–PD-1 therapy in hepatocellular carcinoma with high-risk features after curative resection: A real-world study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e16254